| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Holger Gerhardt | Q38800803 |
| Henrik Semb | Q51626453 | ||
| P2093 | author name string | Holger Gerhardt | |
| Henrik Semb | |||
| P2860 | cites work | Involvement of chemokine receptors in breast cancer metastasis | Q24290909 |
| Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis | Q24313372 | ||
| The Hallmarks of Cancer | Q221226 | ||
| Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis | Q57382204 | ||
| Magnetic Resonance Visualization of Tumor Angiogenesis by Targeting Neural Cell Adhesion Molecules with the Highly Sensitive Gadolinium-Loaded Apoferritin Probe | Q58831586 | ||
| Neural Cell Adhesion Molecule-Deficient β-Cell Tumorigenesis Results in Diminished Extracellular Matrix Molecule Expression and Tumour Cell-Matrix Adhesion | Q64018872 | ||
| Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias | Q73311077 | ||
| Expression of neural cell adhesion molecule in pancreatic cancer | Q73615776 | ||
| Tumor suppressor activity of neural cell adhesion molecule in colon carcinoma | Q73766659 | ||
| Lymphangiogenesis and tumor metastasis | Q79092311 | ||
| Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma | Q80917841 | ||
| Therapeutic targeting of the tumor microenvironment | Q81839382 | ||
| Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis | Q24669710 | ||
| Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors | Q24676378 | ||
| Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis | Q24681191 | ||
| Openings between defective endothelial cells explain tumor vessel leakiness | Q24681507 | ||
| The role of pericytes in blood-vessel formation and maintenance | Q24683881 | ||
| Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development | Q24806905 | ||
| NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis | Q28509922 | ||
| Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis | Q29396371 | ||
| Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 | ||
| A molecular signature of metastasis in primary solid tumors | Q29614442 | ||
| Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice | Q29615196 | ||
| Molecular regulation of angiogenesis and lymphangiogenesis | Q29616150 | ||
| Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors | Q29617042 | ||
| High interstitial fluid pressure - an obstacle in cancer therapy | Q29619719 | ||
| Endothelial/pericyte interactions | Q29619802 | ||
| Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression | Q33267205 | ||
| An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature | Q33751487 | ||
| Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation | Q33771400 | ||
| Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway | Q33896998 | ||
| Endothelial-pericyte interactions in angiogenesis. | Q34217484 | ||
| Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. | Q34309108 | ||
| Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy. | Q34343317 | ||
| PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis | Q34359534 | ||
| Early contribution of pericytes to angiogenic sprouting and tube formation | Q34367285 | ||
| Lymphatic vessels in cancer metastasis: bridging the gaps | Q34511039 | ||
| Heparan sulphate requirement in platelet-derived growth factor B-mediated pericyte recruitment | Q34527775 | ||
| Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? | Q34600828 | ||
| Molecular mechanisms of lymphangiogenesis in health and disease | Q34710547 | ||
| Molecular control of arterial-venous blood vessel identity | Q35066914 | ||
| PDGF receptors as cancer drug targets | Q35142965 | ||
| Angiogenesis, lymphangiogenesis, and melanoma metastasis | Q35146591 | ||
| Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? | Q35167412 | ||
| Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling | Q35649971 | ||
| Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors | Q35788785 | ||
| Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells. | Q35791370 | ||
| Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment | Q35849918 | ||
| Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall | Q35967045 | ||
| Role of pericytes in vascular morphogenesis. | Q35992869 | ||
| Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis | Q36012194 | ||
| Cellular abnormalities of blood vessels as targets in cancer | Q36015542 | ||
| Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies. | Q36251988 | ||
| Pericytes and vascular stability | Q36319680 | ||
| Lymphangiogenesis in development and human disease | Q36342355 | ||
| Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. | Q36365791 | ||
| Lessons from phase III clinical trials on anti-VEGF therapy for cancer | Q36366446 | ||
| Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents | Q36504945 | ||
| Predicting benefit from anti-angiogenic agents in malignancy | Q36534760 | ||
| Genetic determinants of cancer metastasis | Q36794312 | ||
| Molecular mechanisms of lymphatic vascular development | Q36801434 | ||
| Hypoxia and prognosis: the oxygen tension mounts | Q36813772 | ||
| Loss of heterozygosity on chromosome 11 q in breast cancer | Q37261791 | ||
| Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma | Q38444129 | ||
| Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. | Q39740070 | ||
| Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors | Q39961300 | ||
| Neural-cell adhesion molecule (NCAM) expression by immature and tumor-derived endothelial cells favors cell organization into capillary-like structures | Q40331718 | ||
| Angiopoietin 1, PDGF-B, and TGF-beta gene regulation in endothelial cell and smooth muscle cell interaction | Q40593666 | ||
| Expression level of neural cell adhesion molecule (NCAM) inversely correlates with the ability of neuroblastoma cells to adhere to endothelium in vitro | Q40678537 | ||
| Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. | Q40718604 | ||
| Pericytes limit tumor cell metastasis | Q41916240 | ||
| Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly | Q42168707 | ||
| Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development | Q42276166 | ||
| N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken | Q42490043 | ||
| Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation | Q42806733 | ||
| Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms | Q43540251 | ||
| Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors | Q43578049 | ||
| Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy | Q44164588 | ||
| Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy | Q46469087 | ||
| Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticity | Q46744195 | ||
| Microarray analysis of blood microvessels from PDGF-B and PDGF-Rbeta mutant mice identifies novel markers for brain pericytes | Q48483961 | ||
| A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. | Q52529779 | ||
| Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells. | Q53425388 | ||
| P433 | issue | 2 | |
| P921 | main subject | pericyte | Q500446 |
| P304 | page(s) | 135-144 | |
| P577 | publication date | 2007-09-22 | |
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | Pericytes: gatekeepers in tumour cell metastasis? | |
| P478 | volume | 86 |
| Q35015782 | Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection |
| Q36637584 | Adult mesenchymal stem cells and the NO pathways |
| Q26862741 | Anti-angiogenesis and metastasis: a tumour and stromal cell alliance |
| Q35205410 | Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches. |
| Q37883011 | Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? |
| Q30489784 | Characterization of vascular mural cells during zebrafish development |
| Q36627144 | Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis |
| Q37254877 | DLK1: a novel target for immunotherapeutic remodeling of the tumor blood vasculature |
| Q37259213 | Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2 |
| Q35664431 | Dietary restriction promotes vessel maturation in a mouse astrocytoma. |
| Q41313977 | Drugs for solid cancer: the productivity crisis prompts a rethink |
| Q39414887 | Epithelial-to-Pericyte Transition in Cancer. |
| Q22252312 | Hallmarks of Cancer: The Next Generation |
| Q37509823 | Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapy |
| Q30579125 | Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization |
| Q39266457 | Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. |
| Q38094296 | Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor. |
| Q36289382 | Immunohistochemical expression of platelet-derived growth factor receptors in ovarian cancer patients with long-term follow-up. |
| Q49592831 | Immunotherapeutic Targeting of Tumor-Associated Blood Vessels |
| Q38501776 | Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation |
| Q35923153 | Interleukin-6 Stimulates Defective Angiogenesis |
| Q33592374 | Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma |
| Q83260552 | Large hemangiopericytoma associated with arteriovenous malformations and dural arteriovenous fistulae |
| Q64274739 | Limitations of Anti-Angiogenic Treatment of Tumors |
| Q34135852 | Live-cell imaging of invasion and intravasation in an artificial microvessel platform |
| Q46120257 | Low differentiated microvascular density and low expression of platelet-derived growth factor-BB (PDGF-BB) predict distant metastasis and poor prognosis in clear cell renal cell carcinoma |
| Q35025845 | MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis |
| Q34972161 | Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates |
| Q35893461 | Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture |
| Q42571419 | Mesenchymal stem cells regulate melanoma cancer cells extravasation to bone and liver at their perivascular niche |
| Q35034404 | Methylselenocysteine: a promising antiangiogenic agent for overcoming drug delivery barriers in solid malignancies for therapeutic synergy with anticancer drugs |
| Q29547660 | Microenvironmental regulation of metastasis |
| Q29547314 | Molecular mechanisms and clinical applications of angiogenesis |
| Q36500108 | Molecular targeting of liposomal nanoparticles to tumor microenvironment |
| Q38175506 | New biological treatments for gynecological tumors: focus on angiogenesis |
| Q38681238 | Non-coding RNAs in cancer brain metastasis |
| Q27320507 | P-Rex1 cooperates with PDGFRβ to drive cellular migration in 3D microenvironments |
| Q44798933 | PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. |
| Q35024076 | PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. |
| Q27008071 | Pericyte dynamics during angiogenesis: new insights from new identities |
| Q35071289 | Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation |
| Q92421246 | Pericytes in Breast Cancer |
| Q38528174 | Pericytes in sarcomas of bone |
| Q37883025 | Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases |
| Q35221530 | R-Ras protein inhibits autophosphorylation of vascular endothelial growth factor receptor 2 in endothelial cells and suppresses receptor activation in tumor vasculature |
| Q98466507 | Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer |
| Q38126398 | Recruitment and retention: factors that affect pericyte migration. |
| Q37428915 | Regulation of vascular integrity. |
| Q45072551 | Relevance of epithelial-to-pericyte transition in cancer |
| Q27016629 | Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies |
| Q36284948 | Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes |
| Q29615222 | Role of platelet-derived growth factors in physiology and medicine |
| Q35550776 | SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity |
| Q54271815 | Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. |
| Q36174151 | Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels |
| Q30544130 | Spontaneous migration of cancer cells under conditions of mechanical confinement |
| Q37774852 | Targeting the ANGPT-TIE2 pathway in malignancy |
| Q36003362 | The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action |
| Q40076736 | Therapeutic potential of novel modulators of neovascularization |
| Q89638598 | Towards extracellular matrix normalization for improved treatment of solid tumors |
| Q39325325 | Transforming growth factor-beta1 induces microvascular abnormalities through a down-modulation of neural cell adhesion molecule in human hepatocellular carcinoma |
| Q26747678 | Tumor refractoriness to anti-VEGF therapy |
| Q41960757 | Tumor-derived mural-like cells coordinate with endothelial cells: role of YKL-40 in mural cell-mediated angiogenesis |
| Q55690308 | Unraveling the Role of Angiogenesis in Cancer Ecosystems. |
| Q26781833 | Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization |
| Q38126351 | Vascular remodeling in cancer. |
| Q36384149 | Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies? |
Search more.